Prognostic value of oxygenated hemoglobin (OxyHem) in fibrosing interstitial lung diseases

S. Torrisi (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), K. Höger (Heidelberg, Germany), F. Wilkens (Heidelberg, Germany), R. Jörres (Munich, Germany), F. Trudzinski (Heidelberg, Germany)

Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Session: Promising biomarkers for idiopathic interstitial pneumonia
Session type: Oral Presentation
Number: 5190
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Torrisi (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), K. Höger (Heidelberg, Germany), F. Wilkens (Heidelberg, Germany), R. Jörres (Munich, Germany), F. Trudzinski (Heidelberg, Germany). Prognostic value of oxygenated hemoglobin (OxyHem) in fibrosing interstitial lung diseases. 5190

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors of interstitial lung disease (ILD)
Source: Eur Respir J 2001; 18: Suppl. 33, 527s
Year: 2001

Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008


KL-6 as a potential therapeutic biomarker in fibrosing interstitial lung diseases
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 1
Year: 2014

KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019



Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



Prognostic value of SVC change in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004